XOMA Limited (NASDAQ:XOMA)

CAPS Rating: 2 out of 5

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Recs

0
Player Avatar TMFBiologyFool (95.87) Submitted: 3/6/2014 7:03:57 PM : Outperform Start Price: $6.59 XOMA Score: -39.80

Knockdown after EOA data looks like a decent entry point.

Featured Broker Partners


Advertisement